Stay updated on Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.

Latest updates to the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page's revision tag was updated to v3.5.4 from v3.5.3, reflecting a small update to the page's metadata rather than user-facing content.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s revision/version footer was updated from v3.5.2 to v3.5.3, indicating a software release change rather than a modification to the clinical trial information.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded glossary term: Hereditary factor VIII deficiency disease. Removed glossary term: Hemophilia A.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check78 days agoChange DetectedAdded a publication reference (Msihid J et al.) under Publications From PubMed for XTEND-1. The reference summarizes Haemophilia QoL data from XTEND-1.SummaryDifference0.0%

Stay in the know with updates to Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.